Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral meloxicam versus diclofenac for pain after knee arthroplasty
IRCT20221126056613N4Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in postoperative pain and knee osteoarthritis (OA) comparing Meloxicam with Diclofenac (2 arms). Primary endpoint: Intensity of pain. Started May 2023; status: completed.
02
Drugs
meloxicamdiclofenac
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20221126056613N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221126056613N4.